Biotech Values

[NP1986]

I don't disagree with your argument about limited reimbursement dollars, but it could be made for any therapeutic area.

I think if there is a genuine unmet medical need, it would be hard for governments or insurers to refuse to pay for a drug that works, and compromises will ultimately have to be made in other areas.